[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f-q2vBJlSHGAmSfCabNsuzE9sZrweuVsijPXXmDwrM-Q":8,"$fTLcKY_HklKWQx7x6cvvcAVz3NKxsc1CSb01uAu-fyb4":60,"$fAR2GdurFDLaErNj_TYnp3OIz-o_7Y4JzZYRmc2mUyBI":61,"$fQo_9vxsU1xSPOGEUvgo-KqnLQOJ6IIZMoC6JutSXk8A":64},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":59},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"roleType":17,"adept":18,"hospital":19,"department":20,"postsTitle":21,"materialTotal":17,"videoTotal":22,"isConcern":7,"title":23,"coverVertical":24,"coverAcross":25,"directionMarker":26,"description":27,"vid":28,"time":29,"mediaType":26,"views":30,"likes":17,"isThumbsUp":7,"isCollection":7,"collections":17,"createTime":31,"seoTitle":32,"seoKeywords":33,"seoDescription":34,"shelvesTime":35,"menus":36,"menuId":38,"type":55,"quality":56,"commentCount":17,"isComment":26,"deviceType":57,"url":58},9997,871558,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","武鹏涛",0,"全科医疗各类疾病治疗","上海市浦东新区浦兴社区卫生服务中心","全科医疗","主治医师",10,"结缔组织病的肺部表现","","https://cdn.yishi-tong.com/console/3/lEY-x_0iMxD4csy8Bb8W1Cyg7QicqbcU.png",1,"WEBVTT\n\n00:02.344 --> 00:03.019\n大家好，\n\n00:03.019 --> 00:03.293\n嗯，\n\n00:03.293 --> 00:10.444\n今天来讲的是系统性红斑狼疮与系统性硬化症的肺部受累。\n\n00:14.300 --> 00:16.899\n我将从以下几点进行讲解，\n\n00:17.299 --> 00:21.600\n分别是结缔组织病、肺部表现的概述。\n\n00:22.556 --> 00:25.406\n以及系统性红斑狼疮的肺部表现。\n\n00:26.006 --> 00:28.707\n系统性硬化症的肺部表现。\n\n00:29.680 --> 00:36.180\n结缔组织病肺受累的诊断与治疗以及预后与管理。\n\n00:38.212 --> 00:38.611\n首先。\n\n00:40.000 --> 00:42.550\n结缔组织病与肺部受累的关系。\n\n00:43.824 --> 00:45.523\n结缔组织病的定义是，\n\n00:46.223 --> 00:52.773\n一一组以自身免疫介导的器官损害为特征的系统性疾病，\n\n00:53.523 --> 00:55.173\n常累及多器官。\n\n00:56.736 --> 00:59.436\n肺部是常见的受累器官之一，\n\n01:00.035 --> 01:02.835\n可表现为多种肺部疾病，\n\n01:03.535 --> 01:05.835\n严重影响患者的预后。\n\n01:06.585 --> 01:08.386\n它的临床意义是，\n\n01:08.736 --> 01:15.636\n肺部受累是结缔组织病患者发病和死亡的主要原因之一。\n\n01:16.647 --> 01:19.446\n早期识别和治疗至关重要。\n\n01:20.196 --> 01:22.497\n肺部受累的表现多样，\n\n01:23.446 --> 01:29.446\n包括间质性肺病、胸膜病变、肺动脉高压等。\n\n01:30.975 --> 01:43.375\n结缔组织病的肺部受累需要风湿免疫科、呼吸科、放射科等多学科协作进行综合评估和治疗。\n\n01:44.480 --> 01:48.430\n多学科会诊有助于提高诊断准确性，\n\n01:49.029 --> 01:51.379\n制定个性化治疗方案。\n\n01:54.699 --> 01:58.150\n第二部分是系统性红斑狼疮的肺部表现。\n\n01:59.305 --> 02:00.755\n是胸膜病变。\n\n02:01.921 --> 02:04.722\n一是胸膜炎与胸腔积液。\n\n02:05.942 --> 02:08.492\n系统性红斑狼疮患者中，\n\n02:08.942 --> 02:12.641\n胸膜炎是最常见的肺部表现之一。\n\n02:13.397 --> 02:16.996\n发病率为45%.70%。\n\n02:18.179 --> 02:20.229\n患者可表现为胸痛。\n\n02:21.348 --> 02:22.098\n呼吸困难，\n\n02:22.248 --> 02:23.048\n咳嗽，\n\n02:23.848 --> 02:24.973\n胸腔积液，\n\n02:24.973 --> 02:26.348\n多为渗出性，\n\n02:26.397 --> 02:27.798\n双侧多可见。\n\n02:29.292 --> 02:35.242\n他的诊断是胸部X光或CT可显示胸腔积液，\n\n02:35.843 --> 02:40.942\n胸水检查可发现抗结核抗体阳性。\n\n02:41.914 --> 02:43.664\n但不建议常规检测，\n\n02:44.514 --> 02:51.365\n需要与其他原因引起的胸腔积液如感染、心衰等相鉴别。\n\n02:52.626 --> 02:57.276\n轻度胸膜炎可使用非甾体类抗炎药治疗。\n\n02:58.246 --> 03:01.496\n严重者需要使用糖皮质激素治疗，\n\n03:02.296 --> 03:03.746\n预后较好，\n\n03:03.796 --> 03:07.397\n但需注意合并感染等复杂情况。\n\n03:09.119 --> 03:10.869\n第二是肺肺实质病变。\n\n03:12.516 --> 03:13.567\n间质性肺病，\n\n03:13.766 --> 03:21.766\n系统性红斑狼疮相关间质性肺病发生率为1%.15%。\n\n03:22.856 --> 03:26.106\n病理多为非特异性间质性肺炎。\n\n03:27.335 --> 03:31.886\n患者表现为劳力性呼吸困难、干咳。\n\n03:32.852 --> 03:38.302\n肺功能检查提示限制性通气障碍伴弥散障碍。\n\n03:39.102 --> 03:42.503\n第二是急性狼疮性肺炎。\n\n03:43.393 --> 03:45.893\n急性狼疮性肺炎较少见。\n\n03:46.800 --> 03:48.001\n但病情凶险。\n\n03:49.020 --> 03:49.820\n病死率高。\n\n03:50.699 --> 03:53.098\n表现为突发呼吸困难。\n\n03:53.832 --> 03:56.531\n发热、咳嗽、胸痛。\n\n03:57.585 --> 04:01.184\n肺部CT显示双肺大片浸润影。\n\n04:01.983 --> 04:04.483\n需与感染性肺炎相鉴别。\n\n04:05.996 --> 04:06.595\n治疗时，\n\n04:06.645 --> 04:09.695\n糖皮质激素是主要的治疗药物。\n\n04:10.645 --> 04:13.695\n重症患者需联合免疫抑制剂。\n\n04:14.949 --> 04:16.398\n如环磷酰胺。\n\n04:17.936 --> 04:20.985\n硫唑嘌呤等预后差异较大，\n\n04:21.436 --> 04:23.936\n部分患者可自行缓解。\n\n04:25.520 --> 04:28.821\n部分患者可进展为慢性纤维化变。\n\n04:30.191 --> 04:31.691\n还有肺血管病变。\n\n04:33.412 --> 04:34.412\n肺动脉高压，\n\n04:35.062 --> 04:41.863\n系统性红斑狼疮患者中肺动脉高压的发生率为0.5%。\n\n04:42.621 --> 04:44.221\n到17%点5。\n\n04:45.122 --> 04:48.572\n是导致患者死亡的主要原因之一。\n\n04:49.993 --> 04:50.243\n患者，\n\n04:50.243 --> 04:51.093\n表现为？\n\n04:52.759 --> 04:58.109\n活动后气短、乏力、胸痛、眩晕或晕厥。\n\n04:58.959 --> 05:01.959\n体格检查可发现P2亢进。\n\n05:02.904 --> 05:05.204\n三尖瓣收缩期杂音的。\n\n05:06.447 --> 05:07.298\n京胸超。\n\n05:08.713 --> 05:14.114\n心电心动图是筛查肺动脉高压的重要手段。\n\n05:16.398 --> 05:18.898\n确诊需右心导管检查。\n\n05:19.820 --> 05:28.519\n需与其他原因引起的肺动脉高压如特发性结缔组织病相关的相鉴别。\n\n05:29.684 --> 05:32.535\n目前尚无统一的治疗指南。\n\n05:33.704 --> 05:34.704\n糖皮质激素。\n\n05:35.845 --> 05:39.445\n免疫抑制剂、靶向药物等联合应用。\n\n05:40.342 --> 05:42.592\n用于可改善预后，\n\n05:42.641 --> 05:43.691\n预后较差，\n\n05:43.691 --> 05:47.641\n三年的存活率仅约为75%。\n\n05:50.726 --> 05:54.675\n第三部分是系统性硬化症的肺部表现。\n\n05:56.144 --> 05:57.694\n一是间质性肺病。\n\n05:59.570 --> 06:05.070\n病理类型与临床表现系统性硬化症相关。\n\n06:05.420 --> 06:10.970\n间质性肺病是系统性硬化症最常见的肺部表现。\n\n06:12.127 --> 06:15.976\n发生率约为40%.80%。\n\n06:17.069 --> 06:21.118\n病理多为非特异性间质性肺炎，\n\n06:21.769 --> 06:23.819\n患者表现为乏力。\n\n06:24.967 --> 06:25.768\n呼吸急促，\n\n06:26.067 --> 06:26.768\n干咳。\n\n06:28.382 --> 06:29.833\n胸痛反而不常见。\n\n06:31.269 --> 06:31.819\n诊断时，\n\n06:31.919 --> 06:36.819\n高分辨率CT是诊断的其重要手段。\n\n06:37.930 --> 06:39.881\n典型表现为外周。\n\n06:41.183 --> 06:42.033\n磨玻璃影。\n\n06:42.928 --> 06:44.828\n牵拉性支气管扩张。\n\n06:45.786 --> 06:49.087\n需与其他原因引起的间质性肺病。\n\n06:50.084 --> 06:53.434\n如、特发性肺纤维化等相鉴别。\n\n06:54.819 --> 07:00.868\n低剂量的糖皮质激素联合免疫抑制剂是主要治疗方案。\n\n07:01.683 --> 07:02.983\n如环磷酰胺。\n\n07:04.045 --> 07:05.295\n柳嘌唑林等，\n\n07:05.394 --> 07:06.945\n预后差异较大。\n\n07:07.864 --> 07:10.164\n部分患者病情进展缓慢。\n\n07:11.177 --> 07:15.076\n部分患者可进展为严重的限制性肺病。\n\n07:18.897 --> 07:22.997\n肺动脉高压系统性硬化症患者中，\n\n07:23.546 --> 07:29.247\n肺动脉高压的发生率约为13%.35%。\n\n07:30.256 --> 07:33.957\n是导致患者死亡的重要原因之一。\n\n07:35.052 --> 07:39.101\n患者表现为呼吸后气短、乏力。\n\n07:39.985 --> 07:40.436\n胸痛。\n\n07:41.329 --> 07:42.980\n眩晕或晕厥。\n\n07:44.074 --> 07:49.674\n体格检查可发现P2亢进、三尖瓣收缩期杂音等。\n\n07:51.615 --> 07:56.566\n经胸超声心动图是筛查肺动脉高压的重要手段。\n\n07:57.555 --> 07:59.855\n确诊需右心导管检查。\n\n08:01.190 --> 08:04.239\n需与其他原因引起的肺动脉高压，\n\n08:04.690 --> 08:09.890\n如、特发性结缔组织病相关等相鉴别。\n\n08:11.223 --> 08:16.223\n针对肺动脉高压的靶向药物治疗可改善预后。\n\n08:17.441 --> 08:20.191\n如内皮素受体拮抗剂。\n\n08:21.355 --> 08:23.906\n磷酸二酯酶抑制剂等。\n\n08:25.036 --> 08:25.837\n预后较差。\n\n08:26.872 --> 08:30.122\n合并肺动脉高压的患者预后更差。\n\n08:32.513 --> 08:36.414\n其他的肺部表现可表现为胸膜病变。\n\n08:38.021 --> 08:40.771\n系统性硬化症患者可出现。\n\n08:41.679 --> 08:43.879\n胸膜炎、胸腔积液。\n\n08:44.736 --> 08:46.085\n但相对较少见。\n\n08:47.262 --> 08:50.411\n胸腔积液多为少量渗出性。\n\n08:51.380 --> 08:52.130\n症状较轻，\n\n08:52.330 --> 08:54.580\n一般无需特殊治疗。\n\n08:55.856 --> 08:59.656\n还有肺部感染系统性硬化症患者。\n\n08:59.955 --> 09:02.505\n由于免疫功能受损。\n\n09:03.353 --> 09:05.203\n容易发生肺部感染。\n\n09:06.252 --> 09:08.802\n肺部感染可加重肺部受累。\n\n09:09.624 --> 09:11.723\n需积极抗感染治疗。\n\n09:13.533 --> 09:15.083\n同时还有气道疾病。\n\n09:16.109 --> 09:18.408\n部分系统性硬化症患者。\n\n09:19.379 --> 09:21.179\n可出现气道受累。\n\n09:22.257 --> 09:23.557\n表现为干咳。\n\n09:24.856 --> 09:25.757\n呼吸困难等。\n\n09:27.534 --> 09:30.135\n气道受累的机制尚不明确。\n\n09:31.520 --> 09:32.169\n可能与。\n\n09:33.125 --> 09:35.926\n气道炎症纤维化相关。\n\n09:40.570 --> 09:45.421\n第四是结缔组织病肺部受累的诊断与治疗。\n\n09:46.981 --> 09:47.380\n首先，\n\n09:47.380 --> 09:52.580\n诊断方法主要包括病史与体格检查。\n\n09:54.057 --> 09:55.557\n详细询问病史，\n\n09:55.607 --> 10:00.408\n包括症状、既往病史、家族史等。\n\n10:01.864 --> 10:05.713\n体格检查重点是检查肺部和心脏。\n\n10:07.208 --> 10:08.857\n病史和体格检查。\n\n10:09.958 --> 10:14.508\n可初步判断肺部受累的可能性和严重程度。\n\n10:15.870 --> 10:17.471\n第二是实验室检查。\n\n10:18.895 --> 10:22.695\n血清学检查可发现自身抗体阳性。\n\n10:23.888 --> 10:25.288\n如抗核抗体。\n\n10:26.504 --> 10:28.354\n抗双链DNA抗体。\n\n10:29.603 --> 10:31.802\n有助于诊断结缔组织病。\n\n10:33.370 --> 10:37.870\n肺功能检查可评估肺部受累的严重程度。\n\n10:38.968 --> 10:40.818\n包括用力、肺活量。\n\n10:41.617 --> 10:42.668\n弥漫功能等。\n\n10:43.918 --> 10:44.918\n影像学检查。\n\n10:46.036 --> 10:50.536\n高分辨率CT是诊断肺部受累的重要手段。\n\n10:51.911 --> 10:53.960\n可显示间质性肺病。\n\n10:55.083 --> 10:56.283\n肺动脉高压。\n\n10:57.640 --> 10:58.140\n等病变。\n\n10:58.999 --> 11:02.249\n必要时可进行右心导管检查。\n\n11:03.184 --> 11:04.734\n确诊肺动脉高压。\n\n11:06.442 --> 11:07.341\n治疗的策略。\n\n11:08.210 --> 11:11.909\n第一是糖皮质激素与免疫抑制剂。\n\n11:13.030 --> 11:16.179\n糖皮质激素是主要的治疗药物。\n\n11:17.197 --> 11:18.797\n可抑制炎症反应。\n\n11:19.875 --> 11:21.325\n减轻肺部受累。\n\n11:22.518 --> 11:25.568\n免疫抑制剂如环磷酰胺。\n\n11:26.978 --> 11:29.728\n硫唑嘌呤等可联合应用，\n\n11:30.278 --> 11:32.578\n减少糖皮质激素用量。\n\n11:33.443 --> 11:34.794\n提高治疗效果。\n\n11:36.252 --> 11:38.302\n针对肺动脉高压的靶，\n\n11:38.502 --> 11:42.002\n靶向药物治疗可改善预后。\n\n11:42.854 --> 11:45.254\n如内皮素受体拮抗剂。\n\n11:46.247 --> 11:48.947\n磷酸二酯酶五抑制剂的。\n\n11:50.156 --> 11:55.906\n对于重症患者可考虑自身干细胞移植或肺移植。\n\n11:56.945 --> 11:59.395\n第三是支持治疗与康复。\n\n12:00.348 --> 12:04.297\n支持治疗主要包括氧疗、营养支持等。\n\n12:05.383 --> 12:06.883\n可改善患者症状。\n\n12:07.723 --> 12:08.924\n提高生活质量。\n\n12:10.765 --> 12:11.515\n康复治疗，\n\n12:11.515 --> 12:15.616\n如呼吸康复训练、运动康复等。\n\n12:16.952 --> 12:18.552\n可增强患者体质，\n\n12:18.952 --> 12:20.052\n促进康复。\n\n12:22.193 --> 12:23.869\n其实总结来说，\n\n12:23.869 --> 12:28.193\n系统性红斑狼疮与系统性硬化病。\n\n12:29.112 --> 12:31.362\n它的核心机制是有区别的，\n\n12:32.062 --> 12:35.612\n系统性红斑狼疮主要是急性炎症。\n\n12:36.551 --> 12:38.901\n免疫复合物沉淀。\n\n12:39.877 --> 12:44.728\n而系统性硬化病是慢性纤维化以及血管的病变。\n\n12:45.883 --> 12:48.734\n最常见的表现系统性红斑狼疮，\n\n12:48.734 --> 12:50.734\n表现为胸膜炎。\n\n12:51.755 --> 12:55.005\n而系统性硬化症表现为间质性肺病。\n\n12:56.614 --> 12:57.640\n相对来说，\n\n12:57.640 --> 13:02.265\n肺动脉高压在系统性红斑狼疮可发生，\n\n13:02.315 --> 13:03.614\n但相对少见，\n\n13:04.065 --> 13:08.353\n而在系统性硬化症中是非常常见的，\n\n13:08.353 --> 13:10.265\n是主要的死因之一。\n\n13:11.450 --> 13:13.349\n间质性肺炎同样的是。\n\n13:14.398 --> 13:18.249\n在系统性硬化症是极其常见且严重，\n\n13:18.448 --> 13:20.249\n也是主要的死因之一。\n\n13:21.590 --> 13:22.239\n它的特点。\n\n13:23.081 --> 13:24.132\n二者特点不同。\n\n13:24.231 --> 13:26.231\n系统性红斑狼疮。\n\n13:27.255 --> 13:28.155\n形式多样，\n\n13:28.255 --> 13:29.104\n可急性，\n\n13:29.255 --> 13:30.054\n可慢性。\n\n13:31.060 --> 13:34.861\n而系统性硬化症多为隐匿性进展，\n\n13:35.260 --> 13:37.661\n以慢性纤维化为核心。\n\n13:39.875 --> 13:41.775\n治疗的重点也有所区别。\n\n13:42.752 --> 13:47.153\n系统性红斑狼疮侧重于强力抗炎、免疫抑制。\n\n13:48.169 --> 13:49.919\n而系统性硬化病。\n\n13:50.971 --> 13:57.171\n主要是抗纤维化以及血管的靶向治疗及免疫免疫抑制。\n\n14:00.098 --> 14:00.948\n它在预后与。\n\n14:01.895 --> 14:02.344\n管理。\n\n14:03.690 --> 14:07.291\n不同类型的结缔组织病预后差异较大。\n\n14:08.156 --> 14:10.755\n系统性硬化症预后相对较差。\n\n14:11.952 --> 14:16.101\n肺部受累的严重程度是影响预后的重要因素。\n\n14:17.034 --> 14:20.284\n如间质性肺病的纤维化程度。\n\n14:21.116 --> 14:23.416\n肺动脉高压的严重程度等。\n\n14:24.768 --> 14:27.568\n治疗反应良好的患者预后较好。\n\n14:28.611 --> 14:31.611\n但部分患者对治疗反应不佳。\n\n14:33.098 --> 14:34.197\n治疗依从性差，\n\n14:34.197 --> 14:36.098\n可导致病情反复，\n\n14:36.447 --> 14:38.148\n常常影响到预后。\n\n14:40.005 --> 14:42.005\n在这里给患者的建议是，\n\n14:42.406 --> 14:45.156\n一、要定期筛查至关重要。\n\n14:46.010 --> 14:47.710\n即使没有明显的症状。\n\n14:49.000 --> 14:52.851\n两类疾病的患者也应定期进行肺部的检查。\n\n14:54.328 --> 14:56.478\n第二是要警惕症状变化。\n\n14:57.395 --> 15:00.294\n密切关注任何新的或加重的，\n\n15:00.294 --> 15:04.494\n如咳嗽、气短、胸痛、疲劳等症状。\n\n15:05.273 --> 15:08.122\n并及时向风湿免疫科医生反映。\n\n15:09.278 --> 15:11.429\n第三是多学科的合作，\n\n15:11.578 --> 15:17.129\n有效的管理需要风湿免疫科、呼吸科、心内科。\n\n15:18.091 --> 15:20.692\n甚至影像科医生多学科协作。\n\n15:21.765 --> 15:23.864\n第四是要保持积极的心态。\n\n15:24.806 --> 15:27.205\n虽然肺部受累是严重的挑战。\n\n15:28.163 --> 15:30.413\n但近年来医学发展迅猛，\n\n15:30.413 --> 15:33.213\n新的药物和疗法不断涌现，\n\n15:33.763 --> 15:40.513\n早诊断、早治疗、规范随访是改善预后、提高生活质量的关键。\n\n15:44.250 --> 15:44.901\n谢谢大家。\n\n","v0d47cg10004d60rskiljhtcp1r7i1t0",947,664,"2026-01-24 21:53:34"," 结缔组织病的肺部表现 - 症状、诊断与治疗  \n"," 结缔组织病, 肺部表现, 间质性肺病, 肺纤维化, 结缔组织病并发症, 呼吸系统症状, 风湿病肺部病变, 自身免疫性肺病  \n"," 本文详细解析结缔组织病的肺部表现，包括常见症状如间质性肺病、肺纤维化等，探讨诊断方法和治疗方案，帮助患者及医生更好地理解和管理此类并发症。","2026-04-04 21:00:00",[37],{"menuId":38,"menuName":39,"parentId":17,"orderNum":40,"path":41,"component":42,"isFrame":43,"isCache":44,"menuType":45,"visible":26,"status":17,"createDept":6,"remark":24,"createTime":46,"children":47,"columnImage":48,"columnLogo":49,"uncheckedLogo":6,"checkedLogo":6,"isHot":17,"isHome":17,"forceLogin":17,"color":6,"seoTitle":50,"seoKeywords":51,"seoDescription":52,"contentNum":6,"promotionalPoster":53,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":54,"routerPath":41,"componentInfo":42},"1986622624134549505","科普视频",3,"video","/video.html","1","0","T","2025-11-07 10:31:58",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:40/0d7fcb56-3dc4-4dcb-99ca-a5d5c438378e.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:43/958efac7-dd02-4681-b8fd-0dd84b1bbf42.png","健康科普视频大全,了解你的健康生活","健康科普视频, 戒烟视频, 饮食健康视频, 胸痛科普, 用药知识, 职业健康视频, 贫血科普, 眼健康视频","精选健康科普视频,涵盖戒烟、胸痛、饮食、用药与职业健康等多个主题,让你轻松获取科学健康知识,提升生活质量。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:45/fa8fe113-deaa-4454-8105-d629769963dd.png","Video",2,"慢性病,重大疾病",4,"https://vod.haohuanjiao.com/huanjiao/specialistVideo/871558/3a632a43-9f16-44ee-a32f-00e2f9883878.tmp?a=0&auth_key=1789027097-f78d7dd509e042e1a82854a0d6583fdf-0-3cd891fcc782a3758de06f1cddee3219&br=542&bt=542&cd=0%7C0%7C0&ch=0&cr=0&cs=0&dr=0&ds=4&eid=v0d47cg10004d60rskiljhtcp1r7i1t0&er=0&l=202608110542270C74408868E7A3041AAC&lr=&mime_type=video_mp4&net=0&pl=0&qs=13&rc=MzQ6NGZrb251OTczNGY3M0Apd2x1c3dtbHYzZzMzajpneWdxZm9tcWdmcC1hLS1kNGFzcy0uNC5gZWlobzMxLS5gMS06Yw%3D%3D&vl=&vr=",true,{"code":9,"msg":58,"message":6,"data":6,"success":59},{"code":9,"msg":10,"message":6,"data":62,"success":59},{"pageNo":26,"pageSize":22,"result":63,"totalSize":17},[],{"code":9,"msg":10,"message":6,"data":65,"success":59},{"authors":66,"appraiseDimensionScoresVos":67},[],[]]